Angiotensin I-converting enzyme inhibitory activity of enzymatic hydrolysates of goat milk protein fractions

International Dairy Journal

Volumn 32, Issue 2, 2013, Pages 175-183

  Espejo Carpio, F Javier ^a,b   De Gobba, Cristian ^b   Guadix, Antonio ^a   Guadix, Emilia M ^a   Otte, Jeanette ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACE-INHIBITORY ACTIVITY; ANGIOTENSIN I-CONVERTING ENZYME; ANGIOTENSIN-CONVERTING ENZYME; ENZYMATIC HYDROLYSATES; INHIBITORY ACTIVITY; INHIBITORY PEPTIDES; MEMBRANE PROCESS; STRUCTURAL SIMILARITY;

CASEIN; DAIRY PRODUCTS; HYDROLYSIS; PEPTIDES;

ENZYME ACTIVITY;

EID: 84879466907     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2013.04.002     Document Type: Article

References (56)

1. Adler-Nissen J. Enzymic hydrolysis of food proteins 1986, Elsevier Applied Science Publishers, Londo, UK.
2. Bazinet L., Firdaous L. Membrane processes and devices for separation of bioactive peptides. Recent Patents on Biotechnology 2009, 3:61-72.
3. Bernacka H. Health-promoting properties of goat milk. Medycyna Weterynaryjna 2011, 67:507-511.
4. Broncano J.M., Otte J., Petrón M.J., Parra V., Timon M.L. Isolation and identification of low molecular weight antioxidant compounds from fermented "chorizo" sausages. Meat Science 2010, 90:494-501.
5. Chiba H., Yoshikawa M. Bioactive peptides derived from food proteins. Kagaku to Seibutsu 1991, 29:454-458.
6. Espejo-Carpio F.J., Pérez-Gálvez R., Guadix E.M., Guadix A. Optimisation of the hydrolysis of goat milk protein for the production of ACE-inhibitory peptides. Journal of Dairy Research 2013, 80:214-222.
7. Field R.W., Wu D., Howell J.A., Gupta B.B. Critical flux concept for microfiltration fouling. Journal of Membrane Science 1995, 100:259-272.
8. Fitzgerald R.J., Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. British Journal of Nutrition 2000, 84:S33-S37.
9. FitzGerald R.J., Murray B.A., Walsh D.J. Hypotensive peptides from milk proteins. Journal of Nutrition 2004, 134:980-988.
10. Geerlings A., Villar I.C., Zarco F.H., Sánchez M., Vera R., Zafra A., et al. Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk. Journal of Dairy Science 2006, 89:3326-3335.
11. Gómez-Ruiz J.A., Taborda G., Amigo L., Recio I., Ramos M. Identification of ACE-inhibitory peptides in different Spanish cheeses by tandem mass spectrometry. European Food Research and Technology 2006, 223:595-601.
12. Guadix A., Guadix E., Páez-Dueñas M.P., González-Tello P., Camacho F. Procesos tecnológicos y métodos de control en la hidrólisis de proteínas. Ars Pharmaceutica 2000, 41:79-89.
13. Hernandez-Ledesma B., Amigo L., Recio I., Bartolome B. ACE-inhibitory and radical scavenging activity of peptides derived from β-lactoglobulin f(19-25). Interactions with ascorbic acid. Journal of Agricultural and Food Chemistry 2007, 55:3392-3397.
14. Hernández-Ledesma B., Recio I., Ramos M., Amigo L. Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin. International Dairy Journal 2002, 12:805-812.
15. Jäkälä P., Vapaatalo H. Antihypertensive peptides from milk proteins. Pharmaceuticals 2010, 3:251-272.
16. Jiang J., Chen S., Ren F., Luo Z., Zeng S.S. Yak milk casein as a functional ingredient: preparation and identification of angiotensin-I-converting enzyme inhibitory peptides. Journal of Dairy Research 2007, 74:18-25.
17. Jiang Z., Tian B., Brodkorb A., Huo G. Production, analysis and invivo evaluation of novel angiotensin-I-converting enzyme inhibitory peptides from bovine casein. Food Chemistry 2010, 123:779-786.
18. Korhonen H. Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods 2009, 1:177-187.
19. Lee K.J., Kim S.B., Ryu J.S., Shin H.S., Lim J.W. Separation and purification of angiotensin converting enzyme inhibitory peptides derived from goat's milk casein hydrolysates. Asian-australasian Journal of Animal Sciences 2005, 18:741-746.
20. Li G.H., Le G.W., Shi Y.H., Shrestha S. Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 2004, 24:469-486.
21. López-Fandiño R., Otte J., van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal 2006, 16:1277-1293.
22. Maeno M., Yamamoto N., Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a roteinase from Lactobacillus helveticus CP790. Journal of Dairy Science 1996, 79:1316-1321.
23. Manso M.A., López-Fandiño R. Angiotensin I converting enzyme-inhibitory activity of bovine, ovine, and caprine κ-casein macropeptides and their tryptic hydrolysates. Journal of Food Protection 2003, 66:1686-1692.
24. Mao X.Y., Ni J.R., Sun W.L., Hao P.P., Fan L. Value-added utilization of yak milk casein for the production of angiotensin-I-converting enzyme inhibitory peptides. Food Chemistry 2007, 103:1282-1287.
25. Marczak E.D., Usui H., Fujita H., Yang Y., Yokoo M., Lipkowski A.W., et al. New antihypertensive peptides isolated from rapeseed. Peptides 2003, 24:791-798.
26. Meisel H. Overview on milk protein-derived peptides. International Dairy Journal 1998, 8:363-373.
27. Minervini F., Algaron F., Rizzello C.G. Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Applied and Environmental Microbiology 2003, 69:5297-5305.
28. Mota M.V.T., Ferreira I.M.P.L.V.O., Oliveira M.B.P., Rocha C., Teixeira J.A., Torres D., et al. Trypsin hydrolysis of whey protein concentrates: characterization using multivariate data analysis. Food Chemistry 2006, 94:278-286.
29. Nagpal R., Behare P., Rana R., Kumar A., Kumar M., Arora S., et al. Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food and Function 2011, 2:18-27.
30. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of Dairy Science 1995, 78:777-783.
31. Ong L., Henriksson A., Shah N.P. Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Lait 2007, 87:149-165.
32. Otte J., Shalaby S.M.A., Zakora M., Nielsen M.S. Fractionation and identification of ACE-inhibitory peptides from α-lactalbumin and β-casein produced by thermolysin-catalysed hydrolysis. International Dairy Journal 2007, 17:1460-1472.
33. Otte J., Shalaby S.M.A., Zakora M., Pripp H.A., El-Shabrawy S.A. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effects of substrate, enzyme and time of hydrolysis. International Dairy Journal 2007, 17:488-503.
34. Pan D., Cao J., Guo H., Zhao B. Studies on purification and the molecular mechanism of a novel ACE inhibitory peptide from whey protein hydrolysate. Food Chemistry 2012, 130:121-126.
35. Park Y.W., Juárez M., Ramos M., Haenlein G.F.W. Physico-chemical characteristics of goat and sheep milk. Small Ruminant Research 2007, 68:88-113.
36. Parrot S., Degraeve P., Curia C., Martial-Gros A. Invitro study on digestion of peptides in Emmental cheese: analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides. Food 2003, 47:87-94.
37. Pihlanto-Leppälä A., Koskinen P., Piilola K., Tupasela T., Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research 2000, 67:53-64.
38. Pihlanto-Leppälä A., Rokka T., Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal 1998, 8:325-331.
39. Pintado M.E., Malcata F.X. Hydrolysis of ovine, caprine and bovine whey proteins by trypsin and pepsin. Bioprocess Engineering 2000, 23:275-282.
40. Pouliot M., Pouliot Y., Britten M. On the conventional cross-flow microfiltration of skim milk for the production of native phosphocaseinate. International Dairy Journal 1996, 6:105-111.
41. Pripp A.H., Isaksson T., Stepaniak L., Sørhaug T. Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. European Food Research and Technology 2004, 8:579-583.
42. Punidadas P., Rizvi S.S.H. Separation of milk proteins into fractions rich in casein or whey proteins by cross flow filtration. Food Research International 1998, 31:265-272.
43. Quirós A., Contreras M., Ramos M., Amigo L., Recio I. Stability to gastrointestinal enzymes and structure-activity relationship of β-casein-peptides with antihypertensive properties. Peptides 2009, 30:1848-1853.
44. Quirós A., Hernández-Ledesma B., Ramos M., Amigo L., Recio I. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. Journal of Dairy Science 2005, 88:3480-3487.
45. Robert M.C., Razaname A., Mutter M., Juillerat M.A. Identification of angiotensin-I-converting enzyme inhibitory peptides derived from sodium caseinate hydrolysates produced by Lactobacillus helveticus NCC 2765. Journal of Agricultural and Food Chemistry 2004, 52:6923-6931.
46. Rogalewicz F., Hoppilliard Y., Ohanessian G. Fragmentation mechanisms of α-amino acids protonated under electrospray ionization: a collision activation and ab initio theoretical study. International Journal of Mass Spectrometry 2000, 195-196:565-590.
47. Saito T. Antihypertensive peptides derived from bovine casein and whey proteins. Bioactive components of milk 2008, 295-317. Springer, New York, NY, USA. Z. Bösze (Ed.).
48. Sakaguchi M., Ishikawa C., Nishimura T., Sugihara E., Matsumura E. Neurite outgrowth-stimulating peptide derived from bovine kappa-casein. Bioscience, Biotechnology, and Biochemistry 2004, 68:2653-2655.
49. Samuelsson G., Dejmek P., Trägårdh G., Paulsson M. Minimizing whey protein retention in cross-flow microfiltration of skim milk. International Dairy Journal 1997, 7:237-242.
50. Sentandreu M.A., Toldra F. Arapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme. Food Chemistry 2006, 97:546-554.
51. Tauzin J., Miclo L., Gaillard J.L. Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine αS2-casein. FEBS Letters 2002, 531:369-374.
52. Wang L., Mao X., Cheng X., Xiong X., Ren F. Effect of enzyme type and hydrolysis conditions on the invitro angiotensin I-converting enzyme inhibitory activity and ash content of hydrolysed whey protein isolate. International Journal of Food Science and Technology 2010, 45:807-812.
53. Whitworth J.A. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 2003, 21:1983-1992.
54. Wu J., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues. QSAR and Combinatorial Science 2006, 25:873-880.
55. Wu J., Aluko R.E., Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship of di- and tripeptides. Journal of Agricultural and Food Chemistry 2006, 54:732-738.
56. Xu J.Y., Qin L.Q., Wang P.Y., Li W., Chang C. Effect of milk tripeptides on blood pressure: a metaanalysis of randomized controlled trials. Nutrition 2008, 24:933-940.